Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 298,653 | 318,043 | 230,155 | 193,731 | 66,194 |
Marketable Securities | 381,679 | 255,678 | 42,649 | 135,688 | 171,452 |
Receivables | 251,459 | 211,174 | 178,563 | 173,085 | 85,703 |
Inventories | 321,299 | 393,393 | 348,773 | 252,325 | 248,945 |
Income taxes - deferred | 90,202 | 106,640 | 77,416 | 56,703 | 86,900 |
Other current assets | 0 | 0 | 0 | 45,496 | 142,067 |
TOTAL | $1,370,186 | $1,323,489 | $913,451 | $889,738 | $831,345 |
Non-Current Assets | |||||
PPE Net | 427,377 | 424,995 | 304,667 | 234,911 | 194,487 |
Investments And Advances | 41,299 | 50,096 | 75,435 | 113,086 | 76,134 |
Intangibles | 1,368,341 | 1,456,890 | 1,335,315 | 1,268,924 | 1,444,545 |
Other Non-Current Assets | 30,280 | 27,130 | 34,596 | 21,675 | 33,387 |
TOTAL | $1,867,297 | $1,959,111 | $1,750,013 | $1,638,596 | $1,748,553 |
Total Assets | $3,237,483 | $3,282,600 | $2,663,464 | $2,528,334 | $2,579,898 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | N/A | N/A | 83,360 | 68,102 | 52,882 |
Accounts payable and accrued liabilities | 192,701 | 215,388 | 172,363 | 159,809 | 200,965 |
Other current liabilities | N/A | N/A | N/A | 6,448 | 7,658 |
TOTAL | $255,629 | $338,685 | $375,465 | $245,125 | $280,440 |
Non-Current Liabilities | |||||
Long Term Debt | 587,653 | 722,535 | 331,877 | 415,703 | 483,272 |
Deferred Revenues | 5,077 | 11,315 | 8,177 | N/A | N/A |
aiOther Non-Current Liabilities | 4,736 | 9,641 | 5,948 | 9,311 | 12,249 |
TOTAL | $744,905 | $886,569 | $489,715 | $611,159 | $751,489 |
Total Liabilities | $1,000,534 | $1,225,254 | $865,180 | $856,284 | $1,031,929 |
Shareholders' Equity | |||||
Shares Outstanding, K | 110,011 | 108,699 | 106,941 | 106,482 | N/A |
Common Shares | 362 | 357 | 353 | 351 | 348 |
Retained earnings | 1,346,867 | 1,201,714 | 998,850 | 823,054 | 706,693 |
Other shareholders' equity | 9,518 | 14,268 | 1,984 | 57,903 | 82,168 |
TOTAL | $2,236,949 | $2,057,346 | $1,798,284 | $1,672,050 | $1,547,969 |
Total Liabilities And Equity | $3,237,483 | $3,282,600 | $2,663,464 | $2,528,334 | $2,579,898 |